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The program ‘Via verde do AVC’ has been implemented in Portugal since 2005, with the
objective  of reducing mortality by stroke. Mortality rates from stroke have been decreasing,
but  no studies have been done measuring the link between this trend and ‘Via verde do
AVC’.
This  study aims to assess whether the program has achieved signiﬁcant health gains. We
rely  on two data sources: individual level hospital data on ischemic stroke admissions and
regional  level stroke mortality rates.
For both types of data we ﬁnd no evidence that ‘Via verde do AVC’ had a statistically
signiﬁcant impact on ischemic stroke mortality.
©  2012 Escola Nacional de Saúde Pública. Published by Elsevier España, S.L. All rights
reserved.
Programa  “Via  verde  do  AVC”:  análise  do  impacto  sobre  a  mortalidade  do
AVC
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Intervenc¸ão
r  e  s  u  m  o
O programa “Via verde do AVC” foi implementado em Portugal desde 2005, com o objetivo
de  reduzir a mortalidade por AVC. As taxas de mortalidade por AVC têm vindo a diminuir,
mas  nenhum estudo tentou medir a ligac¸ão  entre esta tendência e a “Via verde do AVC”.
Este estudo pretendeu avaliar se o programa conseguiu ganhos signiﬁcativos de saúde.
Contámos  com 2 fontes de dados: dados hospitalares a nível individual de internamentos
Efetividade
GDH
por  AVC isquémico e taxas regionais de mortalidade por AVC.
Para  ambos os tipos de dados não encontrámos qualquer evidência de a “Via verde do
AVC”  ter um impacto estatisticamente signiﬁcativo sobre a mortalidade do AVC isquémico.
© 2012 Escola Nacional de Saúde Pública. Publicado por Elsevier España, S.L. Todos os
direitos reservados.∗ Corresponding author.
E-mail  address: mig@ucp.pt (M. Gouveia).
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troke
s deﬁned by WHO,  stroke is a cerebrovascular disease (CVD)
caused  by the interruption of the blood supply to the brain,
sually  because a blood vessel bursts [hemorrhagic stroke] or
s blocked by a clot [ischemic stroke].”1
There are 15 million people suffering from stroke every
ear  – a trend that is expected to hold in the future. Of those,
.5  million die and other 5 million are left permanently dis-
ble.  It is the third cause the death in the World (10%), only
xceeded by coronary heart disease (13%) and cancer (12%).2
Vascular diseases are the number one cause of death
lso  in Portugal. They are responsible for almost 40% of
ortality,3 and of those, approximately 45% are caused by
troke.  In 2004, the standardized mortality by stroke was 97.6/
00.000  inhabitants, with large regional asymmetries.4
Despite the efforts devoted to the development of more
ffective drugs,5 intravenous rt-PA (recombinant tissue plas-
inogen  activator) is the only approved treatment for stroke;
t  is only effective for acute ischemia – responsible for about
0%  of the total stroke episodes, and can only be used within
 h after the beginning of symptoms.
For this reason – and  given the fact that up to 70% of mortal-
ty  by stroke occurs before arrival to the hospital,6 the National
ealth  Plan and the National Program for Prevention and Con-
rol  of CVD have deﬁned speciﬁc strategies and targets to
educe  both the standardized mortality rate, in particular for
eople  below 65 years old, and in-hospital mortality by stroke.4
n order to achieve these targets, the program ‘Via verde do
VC’  has been implemented across the country since 2005 and
he  entire process followed by patients was  redesigned.
The process is initiated by a phone call to the emergency
umber (112) and redirected to a local and specialized call cen-
er  (CODU) that coordinates the operations until the arrival of
he  patient to the hospital (Pre-hospital Stage). When arrived
t  the hospital, a battery of exams are done, in order to cer-
ify  that the patient fulﬁlls all the medical requirements for
t-PA  administration (In-hospital Stage). For those who sur-
ive  but are not fully recovered from the stroke episode, there
s  a net of rehabilitation services, intended to provide assis-
ance  to the patients after the in-hospital period (Post-hospital
tage/Rehabilitation). For further details, see the reports from
he  “Coordenac¸ão  Nacional para as Doenc¸as  Cardiovascu-
ares”.Via verde applies only to patients 18 or older and up
o  80 years old.
troke  programs  worldwide
n response to programs  aimed at reducing blood pressure and
moking,  the incidence of stroke in developed countries has
een  declining in the recent years.7 Nevertheless, the overall
ates  are still high, and many  countries (such as USA, Den-
ark,  Spain and Netherlands) have already introduced stroke
rograms  speciﬁcally targeted to stroke patients.
Investments have been made in educational programs
o  increase awareness of procedures for initial assessment,
cute treatment, and transport of potential stroke patients.8 0 1 2;3  0(2):172–179  173
Intra-hospital changes have also been introduced during the
last  decade, aimed to reduce delays in medical response.9,10
Organizational changes in both pre- and intra-hospital
stages as done in Spain, analyzed through time, have trans-
lated  not only in more  patients treated with rt-PA, but also
in  a signiﬁcantly larger percentage of patients who  achieve
functional independence after 3 months.11
Another important aspect is the post-hospital stage
of  stroke, as rehabilitation can also deliver signiﬁcant
health gains for stroke patients – shorter admission
times, greater independence, improvement in quality of life
and  greater probability of home discharge instead of long-tem
care.12
Moreover, cost-effectiveness studies carried out in the
USA,13 Spain,14 and in Netherlands15 show that these orga-
nizational changes in stroke assistance have translated into
cost  savings, while generating health gains.
In short, when properly planned and implemented, it can
be  said that organizational change can facilitate and support
scientiﬁc  advances, achieving both health gains and cost sav-
ings.  In this sense, this work aims to assess whether the “Via
verde  do AVC” (VV-AVC) program in Portugal has achieved sig-
niﬁcant health gains and, if not, what might be the reasons
for  such result.
Data  collection  and  methodology
The analysis was  performed by studying individual level in-
patient  hospital data on stroke admissions and by studying
regional level stroke mortality rates, in order to search for a
link  between the existence of Via verde and a reduction in
stroke  mortality.
In  the analysis of in-hospital mortality each observation
corresponds to a single stroke episode, and only the episodes
treated  in an hospital are considered, while the regional analy-
sis  is based on regionally aggregated data, taking into account
all  the cases in which stroke was stated as the cause of
death.  Moreover, in the ﬁrst approach the clinical outcome
is  survival or death of stroke patients, while in the second
analysis the outcome variable is the stroke mortality rate per
100.000  inhabitants.
In  both cases the methodology used will be the differences-
in-differences approach. This approach is used often and it
ensures  that the results are valid even if other factors are
changing mortality rates over time. An example of the use
of  differences in differences in Economics can be seen in the
work  of Meyer.16 The basic idea is illustrated in Fig. 1, where
the  approach ﬁlters out other changes from the analysis by
looking  at how changes over time differ between areas and
years  where VV-AVC was initiated and areas and years with-
out  VV-AVC. A limitation of the analysis is that it assumes
changes over time would be similar for both types of areas if
there  were no VV-AVC.
In-hospital  mortalityClinical information on stroke patients for in-hospital mor-
tality  this analysis considers only Health Regions North and
Algarve,  since these were  the only regions with consistent
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Stroke
mortality rate
Differences
before VV
Impact=differences
of differences
Differences
after VV
Time
Hospital starting VV-AVC between 2004 and 2009
Hospitals not starting VV-AVC
from  INE databases. The information previously collected con-Fig. 1 – How “differences-in-differences” works.
data available on the VV-AVC starting dates. It was  collected
from  the annual DRG databases (known as GDH in Portugal).
Data  on the starting date of the program in each of the rele-
vant  hospitals were  collected from ofﬁcial reports and press
releases  published by ARS Norte and Algarve. Based on the
opinion  of medical experts, the relevant episodes selected had
a  ﬁrst diagnosis (ICD 9 CM)  with codes 433 or 434 – ischemic
stroke, which are the program’s  target. These criteria have
been  used previously in published work.17,18 Since VV-AVC
started in 2005, and the analysis requires data from before
and  after the program’s  introduction in each hospital (as well
as  data from hospitals without VV-AVC), the time frame con-
sidered  was  from 2004 to 2009. For other Health Regions we
were  not able to ﬁnd a comprehensive list with the starting
dates  of VV-AVC by hospital.
The  criteria speciﬁed earlier lead to a selection of
28.837 episodes. This data were  analyzed by logistic regression
performed with STATA 10. The hospitals considered and the
VV-AVC  starting dates are described in Table 1. The explana-
tory  variables used can be seen in Table 2.
To capture the effects of VV-AVC alternative approaches
were  followed:◦  Base case – a single dummy variable (VV) is used to account
for  the existence of the program.
Table 1 – Hospitals under analysis and VV-AVC starting dates.
Hospital Starting date 
H.S. Gonc¸alo  – 
H. Geral Sto. António 15-11-2005 
H. Sta. Maria Maior – 
U.H. Braganc¸a  19-01-2009 
H.S. Marcos 05-02-2007 
U.H. Chaves – 
U.H. Fafe – 
U.H. Famalicão – 
H.S. Sebastião 15-11-2005 
H. Eduardo Santos Silva 03-03-2008  
U.H. Guimarães 01-04-2009 
IPO Porto –  
H. Faro 01-08-2007  . 2 0 1 2;3  0(2):172–179
◦ Breakdown of the impact by year – This approach is meant
to  capture the effect of VV-AVC in a speciﬁc year. The more
people  are aware, prone and able to use the program,  the
greater  the overall impact it can attain. However, since
this  process of change is generally slow, it is predictable
that, as time passes, the program enlarges its coverage and,
consequently, the average impact on the target population
increases.
◦  Breakdown of the impact by expertise – it captures the effect
of  expertise acquired with the practice in Via verde do AVC.
It  is expected that, the longer the existence of the program,
the  better the system performs, which ultimately trans-
lates  into a greater impact on clinical outcomes. For a given
hospital  a set of dummy variables capture the ﬁrst year of
VV-AVC  in that hospital, the second year, and so forth. All
dummy  variables set to zero mean that a hospital never had
VV-AVC.
A  similar analysis was  also performed, limiting the sam-
ple  to 9.014 ischemic stroke episodes of patients with age
higher  than 18 and lower than 65 years old (which is the
range  deﬁned by the National Health Plan as the priority target
group),  instead of a range from 18 to 80 (which is the maximum
range  for clinical intervention).
Regional  mortality
This analysis is limited to subregions in the North Health
Region  (considering the Hospitals mentioned in Table 1, except
H.  Faro and H. Portimão, also due to data limitations). The
North  health Region was  divided into 24 subregions with aver-
age  population of 152.319 (in 2001), as detailed in Table 3. The
data  concerning stroke mortality (standardized mortality rate
– SMR) by subregion, year, gender and age group were  made
available by ARS Norte (the primary source of data being INE).
It  was not possible to limit the analysis to the program’s  tar-
get  population so all deaths by cerebrovascular diseases, for
all  ages, were included.
Data  on population by region through time were  collectedcerning the starting date of VV-AVC in each hospital was  also
used  for this analysis. The time frame considered was  from
2001  to 2009.Regression analysis with 216 observations was
Hospital Starting date
H. S. João 15-11-2005
U.H. Lamego –
U. H. Macedo de Cavaleiros –
H. Pedro Hispano 01-09-2008
U. H. Mirandela –
H. São Miguel –
H. S. Pedro de Vila Real 03-03-2007
U.H. Sto. Tirso –
H. Pe. Américo, V. Sousa 22-06-2009
H. N. Sra. da Conceic¸ão  do Valongo –
U.H. Póvoa do Varzim –
H. Sta. Luzia de Viana do Castelo 01-09-2009
H. Portimão 01-08-2007
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Table 2 – Variables of in-hospital analysis.
Mortality Dependent variable. Dummy variable, referring the ﬁnal outcome: ‘Dead’ (1) or ‘Alive’ (0)
Age Numerical variable, expressing the age of the patient
Gender Dummy variable: male (0) or female (1)
No. of diagnoses Numerical variable counting the number of diagnoses. It ranges from 1 (only stroke diagnosis) up to 20 (stroke and 19
other diagnoses)
Hospital  Dummy variables, indicating the hospital in which the patient was treated
Year Dummy variables, indicating the year in which the episode occurred
VV Variable to measure the programs’ impact in the base-case. Dummy variable, referring the existence of VV-AVC. Value
‘1′ represents ‘Existence of VV-AVC’ (ent1> = date of beginning of the program in a speciﬁed hospital), and value ‘0’
represents ‘Non Existence of VV-AVC’ (remaining cases)
VV Yk Dummy variables are constructed to measure the programs’ breakdown impact by year. Dummy variables (5), refer to
the existence of VV-AVC in a given year. VV Yk equals “1” for the observations that occurred in the year k [k Є(2005;
2009)], in an hospital with VV AVC, and 0 otherwise.
VV kYExpert Variables to measure the programs’ breakdown impact by expertise. Dummy variables (5), referring the longevity of the
program in each hospital. VV kYExpert equals “1” for the observations that occurred within the kth [k Є{1;5}] year of
the program in the speciﬁc hospital, and 0 otherwise
Table 3 – Subregions under analysis, population (in 2001) and Hospitals by subregion.
Subregion Population  (‘01) Hospital Subregion Population (‘01) Hospital
Alto Minho 247.862 Viana Gaia/Espinho 319.905 V. N. Gaia
Gerês/Cabreira 110.058 Braga Gondomar 163.109 Sto. António
Barcelos/Esposende 154.233 Barcelos Valongo 85.417 Valongo
Braga 163.153  Braga Vale Sousa Norte 154.250 Vale Sousa
Terras Basto 78.506 Guimarães Vale Sousa Sul 171.156 Vale Sousa
Guimarães/Vizela 180.858 Guimarães Feira/Arouca 159.073 S. M. Feira
Santo Tirso/Trofa 108.932 Sto. Tirso Aveiro Norte 115.595 S. M. Feira
Famalicão 126.675 Famalicão Baixo Tâmega 187.875 Vale Sousa
Póvoa/Conde 136.838 P. Varzim Douro Sul 79.242 Lamego
Maia 119.939 S. João Marão e Douro Norte 131.538 Vila Real
io 
p
i
•
•
f
TMatosinhos 165.583 Matosinhos 
Porto 258.804 S. João + Sto. Antón
erformed with STATA 10, using multiple linear regressions,
n  two different approaches:
 Simple linear regression
Linear  regression weighted by regional populationAs for in-hospital data, a similar analysis was  performed
or  regional data, including only episodes below 65 years old.
he  variables included are described in Table 4.
Table 4 – Variables in the Regional Analysis.
Standard Mortality Rate Dependent variable. Numerical value,
referring the standard mortality rate in
a given year and region
Region Dummy variables, referring the region
Year  Dummy variables, indicating the year
VV Variable meant to capture the programs’
impact.  VV is equal to “1” for
observations  that occurred in a year and
region  in which there is VV-AVC. For the
year of implementation of the program
in  a given hospital/region, VV equals “1”
only if such implementation occurred
before  June 30 (more than half a year
with VV-AVC)
Population Numerical value, expressing the
population  in a given year and region. It
is used to weight the regression.Alto Tâmega e Barroso 81.451 Chaves
Nordeste 155.614 Braganc¸a
Results
The  in-patient  sample
After selecting episodes from the DRG database, the data were
composed  of 51.603 observations. By excluding hemorrhagic
stroke the sample suffered a 15% reduction. Moreover, when
data  were restricted even further, in order to contain only
those  cases which met  the age criteria of the program,  only
28.837  episodes were  eligible to the activation of “VV-AVC” –
which represents 56% of the total number of stroke episodes
during  the period of 2004–2009 (Fig. 2). In terms of age distri-
bution,  there is a clear dominance of episodes in patients with
ages  between 60 and 90 years old, as shown in Fig. 3.
When  gender is considered without age restrictions, the
incidence  of stroke is similar for men  and women  (Fig. 4), and
this  characteristic holds over time. For stroke patients, the
modal  number of diagnoses other than stroke is 3, and almost
80%  have 5 or less secondary diagnosis (Fig. 5).
Descriptive  statistics
For the in-hospital sample, as described in Table 5, mortality
rates  of stroke patients aged between 18 and 80 are around
8%,  with a standard deviation of approximately 3%.  In terms
of  patient characterization, 56% of them are men, and their
age  is 67 ± 10. Moreover, patients arrive at the hospital with
an  average of about 5 diagnoses.
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Table 5 – Descriptive statistics of data.
In-hospital sample Regional sample
Mortality Sex Age No. diagnostics SMR (simple) SMR (population weighted)
Mean 0.081  0.436 67.28 5.26 100.04 99.27
Std. Dev 0.273 – 10.27 3.46 27.64 27.67
SMR – standardized mortality rate; sex = 0 (male) 1 (female); No. diagnostics – number of diagnosis for each episode in the DRG database.
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When analyzing regional data, statistics show that the
standard mortality rate in the North region is approximately
100/100.000 inhabitants, but when the ratio is weighted by
the  population, it decreases slightly – which means that the
mortality  rate in the most populated subregions is lower than
average.
Regression  analysisThe results of the regressions performed can be seen in Table 6.
When considering the impact of the program on the base case
(ischemic  stroke patients with age above 18 and below 80 years
100
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0
Fig. 3 – Sample distribution by age (cum%).Fig. 4 – Sample distribution by gender (%).
old) as well as the restricted group (aged between 18 and 65),
measured  by a single VV variable, there is no statistical evi-
dence  of impact of VV-AVC on mortality.
Using the breakdown of the intervention variable by exper-
tise,  as well as the breakdown by year, the results obtained
show  similar conclusions: there is no statistically signiﬁcant
decrease in mortality of ischemic stroke patients captured inOn the other hand, the impact of the number of diagnoses
and  age on mortality is highly signiﬁcant in all regressions
R
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frequency ≤ 5=80%
Fig. 5 – Sample distribution by number of second
diagnoses.
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Table 6 – The impact of Via verde do AVC: results of in-hospital analysis.
Scope of analysis Variable Coefﬁcient p > |z| Pseudo R2 Joint test of ﬁxed effects
Ischemic]18;80[ VV
No. of diagnosis
Gender
Age
0.099
0.091
0.087
0.042
0.209
0.000
0.049
0.000
4.09%  hosp id
√
Prob > 2 = 0.00
Year  ∗
Prob > 2 = 0.33
Ischemic]18;65[ VV 0.031 0.863 4.69% hosp id
√
Prob > 2 = 0.00
Year  ∗
Prob > 2 = 0.90
Breakdown by Expertise VV 1YExpert
VV 2YExpert
VV 3YExpert
VV 4YExpert
VV 5YExpert
0.109
0.097
−0.003
−0.020
0.165
0.205
0.347
0.984
0.910
0.644
4.10%  hosp id
√
Prob > 2 = 0.00
Year  ∗
Prob > 2 = 0.45
Breakdown by Year VV  Y2005
VV Y2006
VV Y2007
0.573
0.016
0.202
0.098
0.918
0.101
4.12%  hosp id
√
Prob > 2 = 0.00
Year  ∗
Prob > 2 = 0.42
(
n
p
n
a
w
a
t
m
f
p
t
s
m
e
A
a
6
e
f
r
t
z
P
o
G
s
m
i
p
P
T
t
Training  and  expertise
In order to achieve the best outcomes possible, it is important
that  everybody involved in the process is fully capable and
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–50%VV Y2008
VV Y2009
0.129
−0.027
although only presented in the base-case) – the larger the
umber  of diagnosis or the older the patient, the higher the
robability  of death; gender varies between borderline sig-
iﬁcant  (p-value = 0.049) and non-signiﬁcant, but always with
 positive bias – which translates in a higher propensity for
omen  to die in case of stroke.
In all of these approaches, the vector of hospital dummies
re  jointly signiﬁcantly (p > 2 = 0.00%), while there is no statis-
ical  evidence that time has contributed for a shift on stroke
ortality  (p > 2 around 40% for age]18;80[and higher than 90%
or  age]18;65[).
A  measure of the explanatory power of these analyses (the
seudo  R2) is around 4%.
In conclusion, based on these analyses, it is not possible
o  conclude that the program was  able to improve the health
tatus  of stroke patients through the decrease of in-hospital
ortality, even if the impact is broken down by degree of
xpertise  or year of observation.
The  results of the regional analysis are on display in Table 7.
ccording  to the results obtained in both approaches (simple,
nd  population-weighted), both for age upper-limit of 80 and
5,  once again, there is no statistical evidence that the exist-
nce  of ‘VV-AVC’ in the regions translates into lower mortality
or  stroke patients (p-values ranging from 10% to 30%).
On  the other hand, there are large differences among
egions and throughout the years, since the joint tests show
hat  the respective coefﬁcients are statistically different from
ero  (p > F = 0.00%).
rogram’s  limitations  that  might  explain  the  results
btained
iven the fact that none of the analysis performed showed
igniﬁcant effectiveness of the program VV-AVC in reducing
ortality, it is relevant to focus on the program’s  design and
mplementation strategy, in order to better understand the
ossible  causes that are limiting its success.romotion  and  reach
he trigger of the process is a call to the emergency services at
he occurrence of a stroke episode. In this sense, informative0.304
0.833
campaigns to increase the population’s awareness are critical
for  the success of the program.  However, in Portugal, the pro-
gram  has not been heavily promoted and many  people might
be  still not aware of its existence.
Indeed, when considering the North region (the one with
the  largest adherence rates, based on ofﬁcial reports on the
topic,19 and through time, as more  hospitals implement the
program,  the population covered increases dramatically from
25%  to around 70% (“hospital potential coverage”, the ratio
of  stroke patients in hospitals with VV-AVC and total stroke
patients  in hospitals in the region). However, the percentage of
patients  who are actually using it (“program actual coverage”,
percentage of total stroke patients in the region treated with
rt-PA)  – although increasing at a similar rate –, is only about
half  of the potential number of episodes that could have used
the  program (Fig. 6).
Based on this ﬁgures, it is possible to argue that it is not
enough to create more  infrastructures to tackle the problem:
it  is also critical to involve the population on this program,  to
make  it aware of its existence and thus, to translate potential
impact  into actual impact.0
2006 2007 2008 2009
Fig. 6 – Program’s reach. Sources: .20,21,19
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Table 7 – The Impact of Via verde do AVC: results of regional analysis.
Scope of analysis Variable Coefﬁcient p > |t| Adj R2 Joint test of ﬁxed effects
Simple linear regression VV]18;80[ 2.7 0.3 88.7% Region
√
Prob > F < 0.01 Year
√
Prob > F < 0.01
VV]18;65[ 1.4 0.2 41.9% Region
√
Prob > F < 0.01 Year
√
Prob > F < 0.01
0.1 
0.1 Population-weighted linear
regression
VV]18;80[  4.1 
VV]18;65[ 1.4 
knowledgeable about it. So, training should be continuously
implemented.4
However, when considering data on the time elapsed
since the beginning of symptoms until arrival to the hospital
(“onset-to-door”), not much  improvement has been achieved
since  the implementation of the program,  and approximately
50%  of the patients transported by INEM take longer than
1  hour to arrive at the hospital.22
Along with this goes the fact that, of all the episodes that
meet  the program’s  requirements (ischemic stroke patients
with  age between 18 and 80), only a small fraction has been
treated  with rt-PA (from 1% in 2005 to 7% in 2008), which
means that the ultimate purpose of the program (providing the
stroke  patients with trombolitic treatment) is rarely achieved
and  only a small fraction of the target population is actually
beneﬁting from the process in full (Fig. 7).
Post-hospital  care  and  rehabilitation
Another relevant stage of the stroke process is post-hospital
care. As mentioned before, many  countries have adopted
programs  that include rehabilitation treatment, in order to
improve  the patients health conditions and their functional
status,  since many  of those who survive are still limited in
their  physical conditions.
In  Portugal, in particular, although there is the intention
to  include this stage in the process, there is not much  infor-
mation  concerning its actual implementation and monitoring.
Also,  there is no systematic track of the patients’ health sta-
tus  after hospital discharge, and thus, no information on its
evolution  over time.
For  this reason, and now that the pre- and intra-hospital
stages are already implemented, it would be important
to focus on this issue and to develop mechanisms that
would  allow stroke patients to have comprehensive access to
post-hospital health care services, thus maximizing the
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program’s  reach throughout the whole process of stroke treat-
ment.
Conclusions
Since the program’s  implementation in 2005 until nowadays,
data  have shown a sharp and steady decrease of stroke
mortality in Portugal. However, according to the analysis per-
formed,  considering both in-hospital observations, as well as
population-level data, there is no statistical evidence that such
a  decrease is related to the implementation of ‘Via verde do
AVC’.
In  an attempt to understand the reason for this result, some
possible  explanations were  presented. First of all, the efforts
on  promotion and information campaigns about the program
might  have not been enough to reach as many  people as it
would  be possible and desirable. Second, there is still a very
small  fraction of the target population being treated with rt-PA
drugs.  Finally, the poor implementation of post-hospital care
might  further limit the results of the overall program.
The analysis itself also has some limitations: as it focuses
on  few regions, it is not possible to reach nationwide conclu-
sions;  and in the regional analysis, it was  not possible to fully
match  the sample with the program’s  requirements (stroke
category  and age groups).
In  short, although the results obtained do not show a very
positive  picture, they bring to light some important insights of
what  can be done differently. In this sense, this work should
be  interpreted as a driving force to continuously strive for
the  development of better and more  effective mechanisms,
in  which resources are properly allocated and used – afterall,
“Improvement” is a never-ending process.
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